{
    "SPADE_UN_13534": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13534",
            "Peptide Name": "ACE2 (27-42)(SAP1)",
            "Source": "Synthetic construct",
            "Family": "Belongs to the peptidase M2 family.",
            "Gene": "ACE2",
            "Sequence": "TFLDKFNHEAEDLFYQ",
            "Sequence Length": 16,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Q9BYF1"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral(SARS-CoV-2)"
            ],
            "Target Organism": "[Ref.33356169]Virus:SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=2.39Â±0.20 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);SARS-CoV:Inhibition of infection in 293T/ACE2 cells(80% inhibition at 3 mM);Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C94H129N21O29",
            "Mass": 2017.15,
            "PI": 4.31,
            "Net Charge": -2,
            "Hydrophobicity": -0.77,
            "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.",
            "Literature": [
                {
                    "Title": "Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.",
                    "Pubmed ID": "33356169",
                    "Reference": "Bioconjug Chem. 2021 Jan 20;32(1)215-223.",
                    "Author": "Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33356169"
                }
            ],
            "Frequent Amino Acids": "FDE",
            "Absent Amino Acids": "CGIMOPRSUVW",
            "Basic Residues": 2,
            "Acidic Residues": 4,
            "Hydrophobic Residues": 7,
            "Polar Residues": 7,
            "Positive Residues": 2,
            "Negative Residues": 4,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13538",
                    "Similarity": 1.0,
                    "Sequence": "QAKTFLDKFNHEA"
                },
                {
                    "SPADE_ID": "SPADE_UN_13871",
                    "Similarity": 1.0,
                    "Sequence": "EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR"
                },
                {
                    "SPADE_ID": "SPADE_UN_13872",
                    "Similarity": 1.0,
                    "Sequence": "EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE"
                }
            ]
        }
    }
}